LPL Financial
LAB icon

LPL Financial’s Standard BioTools LAB Stock Holding History

LPL Financial’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Buy
12,553
+1,415
+13% +$1.34K ﹤0.01% 6169
2026
Q1 		$10.2K Sell
11,138
-2,589
-19% -$3.13K ﹤0.01% 5926
2025
Q4 		$17.6K Sell
13,727
-4,160
-23% -$5.59K ﹤0.01% 5817
2025
Q3 		$23.3K Buy
17,887
+33
+0.2% +$43 ﹤0.01% 5728
2025
Q2 		$21.4K Buy
+17,854
New +$19.8K ﹤0.01% 5465

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

LPL Financial's LAB Position: Q2 2026 in Review

LPL Financial increased its Standard BioTools (LAB) stake by 13% in Q2 2026, buying an estimated $1.34K and bringing the position to 12,553 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6169.

LPL Financial first reported a position in LAB in Q2 2025 and has held it in 5 quarters since. The position peaked at $23.3K in Q3 2025. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • LPL Financial held 12,553 shares of Standard BioTools worth $10.3K as of Q2 2026.
  • LPL Financial bought 1,415 Standard BioTools shares in Q2 2026, an estimated $1.34K.
  • Standard BioTools made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6169 holding.
  • LPL Financial first reported a position in Standard BioTools in Q2 2025 and has held it in 5 quarters since.
  • LPL Financial's Standard BioTools position peaked at $23.3K in Q3 2025.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.